PCH
ORKA

Polar Capital Holdings’s Oruka Therapeutics ORKA Stock Holding History

Polar Capital Holdings’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117M Buy
1,228,609
+180,916
+17% +$12.1M 0.28% 74
2026
Q1 		$51.4M Buy
1,047,693
+69,405
+7% +$2.41M 0.18% 94
2025
Q4 		$29.7M Sell
978,288
-54,019
-5% -$1.51M 0.11% 131
2025
Q3 		$19.9M Buy
1,032,307
+57,307
+6% +$849K 0.1% 149
2025
Q2 		$10.9M Sell
975,000
-75,000
-7% -$782K 0.06% 184
2025
Q1 		$10.8M Buy
1,050,000
+500,000
+91% +$6.24M 0.07% 191
2024
Q4 		$10.7M Buy
+550,000
New +$13.4M 0.06% 196

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Polar Capital Holdings's ORKA Position: Q2 2026 in Review

Polar Capital Holdings increased its Oruka Therapeutics (ORKA) stake by 17% in Q2 2026, buying an estimated $12.1M and bringing the position to 1,228,609 shares worth $117M. The position accounts for 0.28% of the portfolio, ranked #74.

Polar Capital Holdings first reported a position in ORKA in Q4 2024 and has held it in 7 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Polar Capital Holdings held 1,228,609 shares of Oruka Therapeutics worth $117M as of Q2 2026.
  • Polar Capital Holdings bought 180,916 Oruka Therapeutics shares in Q2 2026, an estimated $12.1M.
  • Oruka Therapeutics made up 0.28% of Polar Capital Holdings's portfolio in Q2 2026, its #74 holding.
  • Polar Capital Holdings first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.